Atze Akkerman and Elizabeth Akkerivian v. Mecta Corp
Documents from the Atze Akkerman and Elizabeth Akkerivian v. Mecta Corp case, 2004.
Documents from the Atze Akkerman and Elizabeth Akkerivian v. Mecta Corp case, 2004.
A critical look at a study that claims ECT appears to be a low risk treatment.
This article discusses the challenges faced by individuals with cognitive disabilities after undergoing electroconvulsive therapy (ECT). The author draws on personal experiences and research to highlight issues such as societal perception and limited support from social services.
One man shares how cancer treatment led to heavy psychiatric drugging and forced electroconvulsive therapy (ECT.)
Deposition of Robin Nicol, the Owner of Mecta, one of two US ECT device manufacturers.
A letter to the Patient Safety Comminsioner on behalf UK ECT Improving Standards Group.